The store will not work correctly when cookies are disabled.
4-(2,6-difluorophenyl)-5-(3-fluoro-4-(methylsulfonyl)phenyl)-2,2-dimethylfuran-3(2H)-one
ID: ALA3981573
PubChem CID: 18385676
Max Phase: Preclinical
Molecular Formula: C19H15F3O4S
Molecular Weight: 396.39
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: CC1(C)OC(c2ccc(S(C)(=O)=O)c(F)c2)=C(c2c(F)cccc2F)C1=O
Standard InChI: InChI=1S/C19H15F3O4S/c1-19(2)18(23)16(15-11(20)5-4-6-12(15)21)17(26-19)10-7-8-14(13(22)9-10)27(3,24)25/h4-9H,1-3H3
Standard InChI Key: OUBIHSDQGOZVGR-UHFFFAOYSA-N
Molfile:
RDKit 2D
27 29 0 0 0 0 0 0 0 0999 V2000
4.6308 -29.2414 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.2263 -28.5357 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.8173 -29.2388 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.9161 -23.8318 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1.8779 -24.6519 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
2.6072 -24.2750 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
3.5657 -28.0601 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
4.8891 -28.0538 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.6316 -27.2756 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.8153 -27.2832 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.6670 -28.3042 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
3.3321 -26.6261 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.6614 -25.8770 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.1777 -25.2193 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.3646 -25.3095 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.0376 -26.0631 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5234 -26.7176 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.1040 -26.6137 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.9183 -26.6946 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.3936 -26.0308 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.0558 -25.2857 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.2380 -25.2085 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.7663 -25.8733 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.0672 -24.7437 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.5057 -24.4709 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
6.2554 -27.4390 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
3.9528 -25.7961 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
2 1 1 0
3 2 1 0
5 4 2 0
6 5 2 0
7 2 1 0
2 8 1 0
8 9 1 0
9 10 2 0
10 7 1 0
8 11 2 0
12 13 2 0
13 14 1 0
14 15 2 0
15 16 1 0
16 17 2 0
17 12 1 0
10 12 1 0
18 19 2 0
19 20 1 0
20 21 2 0
21 22 1 0
22 23 2 0
23 18 1 0
9 18 1 0
15 5 1 0
5 24 1 0
14 25 1 0
19 26 1 0
23 27 1 0
M END
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 396.39 | Molecular Weight (Monoisotopic): 396.0643 | AlogP: 3.75 | #Rotatable Bonds: 3 |
Polar Surface Area: 60.44 | Molecular Species: NEUTRAL | HBA: 4 | HBD: ┄ |
#RO5 Violations: ┄ | HBA (Lipinski): 4 | HBD (Lipinski): ┄ | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: ┄ | CX LogP: 3.46 | CX LogD: 3.46 |
Aromatic Rings: 2 | Heavy Atoms: 27 | QED Weighted: 0.79 | Np Likeness Score: -0.37 |
References
1. (2002) 4,5-diaryl-3(2H)-furanone derivatives as cyclooxygenase-2 inhibitors, |